| 标题 |
LBA41 Durvalumab (durva) plus carboplatin/paclitaxel (CP) followed by maintenance (mtx) durva ± olaparib (ola) as a first-line (1L) treatment for newly diagnosed advanced or recurrent endometrial cancer (EC): Results from the phase III DUO-E/GOG-3041/ENGOT-EN10 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:S.N. Westin; K.N. Moore; H.S. Chon; J-Y. Lee; J. Thomes Pepin; et al 出版日期:2023-10-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)